Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 14/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 2/20 | 0.35 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.35 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17180542 | 0.97 | PDK2 (0.46) | PDK2MEN1KMT2APGRHPRT1 | |
| SCHEMBL12378952 | 0.96 | PDK2 (0.44) | PDK2PGR | |
| SCHEMBL12378939 | 0.96 | PDK2 (0.46) | PDK2PGR | |
| SCHEMBL17465480 | 0.95 | PDK2 (0.43) | PDK2MEN1KMT2A | |
| SCHEMBL12378963 | 0.95 | PDK2 (0.43) | PDK2MEN1KMT2A | |
| SCHEMBL12378999 | 0.94 | PDK2 (0.44) | PDK2PGR | |
| SCHEMBL12378967 | 0.94 | PDK2 (0.43) | PDK2 | |
| SCHEMBL17153723 | 0.92 | PDK2 (0.48) | PDK2MEN1KMT2APGR | |
| SCHEMBL16366414 | 0.92 | PDK2 (0.48) | PDK2MEN1KMT2APGR | |
| SCHEMBL16366318 | 0.92 | PDK2 (0.48) | PDK2MEN1KMT2APGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288018-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2012-10-16 | — | — | US | disclosed |
| US-8288018-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20110198576-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-08-18 | — | — | US | disclosed |
| US-20110198576-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-08-18 | — | — | US | disclosed |
| US-7960039-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2011-06-14 | — | — | US | disclosed |
| US-7960039-B2 | Amino compound for organic light-emitting device and organic light-emitting device including the same | CANON KABUSHIKI KAISHA (JP) | 2011-06-14 | — | — | US | disclosed |
| US-20070228941-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
| US-20070228941-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070228941-A1 | AMINO COMPOUND FOR ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ARL1, APOL1, UFL1 | PDK2 2514/4885MEN1 1138/4885KMT2A 1915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.